Model NO.:

QS-Tofacitinib Citrate

CAS No.:

540737-29-9

Formula:

C16h20n6o.C6h8o7

EINECS:

638-826-4

Packaging Material:

Negotiable

Storage Method:

Normal

Shelf Life:

>12 Months

Nutrient Composition:

Tofacitinib Citrate

Resource:

Tofacitinib Citrate

The content of active substances:

>99%

Product Name:

Tofacitinib Citrate

Name:

Tofacitinib Citrate Powder

Appearance:

White Powder

Colour:

White

Grade:

Pharmaceutical Grade

Assay:

HPLC 99%

Application:

Pharmaceutical

Test Method:

HPLC

Purity:

>99%

Mf:

C16h20n6o.C6h8o7

MW:

504.497

Melting Point:

201 Oc

Certification:

GMP, Hse, ISO 9001, USP, Bp

Solubility:

5mg/Ml

State:

Powder

Trademark:

Transport Package:

Negotiable

Specification:

negotiable

Origin:

Xi'an

Product Description

Rheumatoid Arthritis Tofacitinib Citrat Intermediate Tofacitinib Citrate

Product Name	Tofacitinib Citrate
Appearance	White Powder
CAS No.	540737-29-9
Mf	C16h20n6o.C6h8o7
Mw	504.497

Tofacitinib citrate, also known as 3- [(3R, 4R) -4-methyl-3- [methyl - (7H-pyrrolo [2,3-d] pyrimidin-4-yl) amino] piperidin-1-yl] -3-oxopropionitrile citrate, is a novel Janus kinase inhibitor developed by in the United States. It can be used in combination with methotrexate to treat active rheumatoid arthritis with insufficient response to tumor necrosis factor inhibitors.

Tofacitinib citrate combined with methotrexate is used to treat active rheumatoid arthritis with insufficient response to tumor necrosis factor inhibitors. Medications for treating rheumatoid arthritis Used for adult patients with moderate to severe active rheumatoid arthritis (RA) who have insufficient or intolerant response to methotrexate treatment. This product is a Janus kinase inhibitor. Tofacitinib citrate is used in adult patients with moderate to severe active rheumatoid arthritis (RA) who have insufficient or intolerant response to methotrexate treatment. Xeljanz can be used as a monotherapy or in combination with methotrexate or other non biological disease relieving antirheumatic drugs (DMARD). This drug should not be used in combination with biological DMARDs or strong immunosuppressants such as azathioprine and cyclosporine.

Message Type
* Message Content
* Name
* Phone
* Email
* CAPTCHA

Rheumatoid Arthritis Tofacitinib Citrat Intermediate Tofacitinib Citrate

Xi'an Qiushi Co., Ltd.